Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Glasses that help you hear: new study tests smart spectacles for hearing loss

NCT ID NCT07282028

Symptom relief Sponsor: Nuance Hearing Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new type of hearing aid that is built into glasses. It is for adults 18 and older who have mild to moderate hearing loss and already wear glasses. The goal is to see if the device helps people hear better in noisy places and is safe to use. About 89 people will take part.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2/3

Runs two stages together: whether the treatment works, then large-scale confirmation.

Participants

About 89 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 years and older * Perceived mild to moderate hearing loss as indicated by at least 1 positive answer to any of the signs specified by FDA: a) You have trouble hearing speech in noisy places, b) You find it hard to follow speech in groups, c) You have trouble hearing on the phone. d) Listening makes youtired, e) You need to turn up the volume on the TV or radio, and other people complain it's too loud * Wearing corrective glasses for daily use * Cognitive ability to understand and follow study instructions. * The main language used in social interactions is Hebrew * Participants must be willing to use the investigational device according to the instructions for use during the study period * Participants must be able to use a smartphone Exclusion Criteria: * Hearing loss \>55 dB HL * Prior hearing aid usages for the last 12 months * Medical history of cognitive or neurological impairment. * Active inflammatory conditions affecting the ear * Asymmetric or unilateral hearing loss - more than 15dB between ears in PTA4- based on screening or hearing test from the last 18 months. * participation in stage 1 study * Congenital ear defect or a deformed or injured ear * In the past 6 months discharge of blood, pus or fluid * Wax that might disturb REM test * Sudden hearing loss in the past 6 months * Wearer of electromagnetic medical device * Other medical conditions/medications that would interfere with subject safety or data collection in the opinion of the PI

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hearing loss, mixed are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hearing loss, mixed conductive-sensorineural

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hearing loss, mixed

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Asssuta ramat hachayal

    RECRUITING

    Tel Aviv, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.